Histamine H2 Antagonists

All categories
DBCAT000933Therapeutic categoryA02BA

Drugs that selectively bind to but do not activate histamine H2 receptors, thereby blocking the actions of histamine. Their clinically most important action is the inhibition of acid secretion in the treatment of gastrointestinal ulcers. A DrugBank category of 20 drugs. 11 of them are approved.

ATC classification
Part of
Histamine Antagonists
Also known as
Antagonists, Histamine H2 · Antihistaminics, H2 · Blockaders, H2 Receptor · Blockaders, Histamine H2 Receptor · Blockers, Histamine H2
Drugs

What you can answer from here — as of May 25, 2021

20DrugsEach linked to its full drug card
Listed above
47Drug targetsEvery drug–target pair in the class, with bond type
Sign in
8,350Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
13Routes of administrationHow the drugs in this class are given
Sign in
1SubcategoryNarrower classes within this one
Sign in

Which targets do Histamine H2 Antagonists share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In